The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of 12-weeks of neoadjuvant TDM1 with or without endocrine therapy in HER2-positive hormone-receptor-positive early breast cancer: WSG-ADAPT HER2+/HR+ phase II trial.
 
Nadia Harbeck
Honoraria - Amgen; Celgene; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Celgene; Genomic Health; Novartis; Roche/Genentech; Sandoz; Wilex
Research Funding - Boehringer Ingelheim (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Oleg Gluz
No Relationships to Disclose
 
Matthias Christgen
No Relationships to Disclose
 
Michael Wilhelm Braun
No Relationships to Disclose
 
Sherko Kummel
Honoraria - Celgene; Novartis; Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
Travel, Accommodations, Expenses - Celgene; Roche Pharma AG
 
Jochem Potenberg
No Relationships to Disclose
 
Bahriye Aktas
No Relationships to Disclose
 
Claudia Schumacher
No Relationships to Disclose
 
Helmut Forstbauer
No Relationships to Disclose
 
Doris Augustin
No Relationships to Disclose
 
Stefan Kraemer
No Relationships to Disclose
 
Marianne Just
No Relationships to Disclose
 
Joke Tio
No Relationships to Disclose
 
Anke Kleine-Tebbe
No Relationships to Disclose
 
Cornelia Liedtke
No Relationships to Disclose
 
Ronald E. Kates
No Relationships to Disclose
 
Daniel Hofmann
No Relationships to Disclose
 
Rachel Wuerstlein
No Relationships to Disclose
 
Hans Heinrich Kreipe
Honoraria - AstraZeneca; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Roche Pharma AG
Expert Testimony - AstraZeneca; Roche Pharma AG
 
Ulrike Nitz
Consulting or Advisory Role - Genomic Health
Research Funding - Roche Pharma AG (Inst)